ZNHIT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.193200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.841400E-01
Normal-vs-Stage2
6.260000E-01
Normal-vs-Stage3
2.124400E-01
Normal-vs-Stage4
6.486800E-01
Stage1-vs-Stage2
2.838800E-01
Stage1-vs-Stage3
1.367160E-01
Stage1-vs-Stage4
5.039000E-01
Stage2-vs-Stage3
2.515800E-01
Stage2-vs-Stage4
9.324400E-01
Stage3-vs-Stage4
3.653400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.339800E-01
Normal-vs-AfricanAmerican
3.675000E-01
Normal-vs-Asian
7.991200E-01
Caucasian-vs-AfricanAmerican
5.746000E-01
Caucasian-vs-Asian
9.707800E-01
AfricanAmerican-vs-Asian
7.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.428600E-01
Normal-vs-Female
8.005000E-01
Male-vs-Female
5.247800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.280200E-01
Normal-vs-Age(41-60Yrs)
9.835200E-01
Normal-vs-Age(61-80Yrs)
5.730200E-01
Normal-vs-Age(81-100Yrs)
6.089000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.410400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.772000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.627800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.626300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.308800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.933000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.303400E-01
Normal-vs-Daily Drinker
7.239000E-01
Normal-vs-Weekly Drinker
1.423390E-01
Normal-vs-Occasional Drinker
6.737600E-01
Normal-vs-Social Drinker
9.863800E-01
Non Drinker-vs-Daily Drinker
3.831800E-01
Non Drinker-vs-Weekly Drinker
9.756400E-01
Non Drinker-vs-Occasional Drinker
1.994020E-02
Non Drinker-vs-Social Drinker
1.662990E-01
Daily Drinker-vs-Weekly Drinker
3.460400E-01
Daily Drinker-vs-Occasional Drinker
1.622960E-01
Daily Drinker-vs-Social Drinker
5.594400E-01
Weekly Drinker-vs-Occasional Drinker
1.204040E-02
Weekly Drinker-vs-Social Drinker
1.562980E-01
Occasional Drinker-vs-Social Drinker
5.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.678020E-01
Normal-vs-Grade 2
4.120100E-02
Normal-vs-Grade 3
1.705770E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.063600E-01
Grade 1-vs-Grade 3
6.872000E-01
Grade 1-vs-Grade 4
1.678020E-01
Grade 2-vs-Grade 3
8.469400E-01
Grade 2-vs-Grade 4
4.120100E-02
Grade 3-vs-Grade 4
1.705770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.527400E-01
Normal-vs-NonDiabetic
8.574000E-01
Diabetic-vs-NonDiabetic
1.348400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.882600E-01
Normal-vs-NoPancreatitis
6.957400E-01
Pancreatitis-vs-NoPancreatitis
4.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.794200E-01
Normal-vs-N1
6.588200E-01
N0-vs-N1
5.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.376000E-01
Normal-vs-TP53-NonMutant
6.693600E-01
TP53-Mutant-vs-TP53-NonMutant
3.358400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
